Evidence map›Paper›PMID 33444603›Full record

ArticlePharmacology, biochemistry, and behavior2021

Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses.

Fernando B de Moura, Alexander Sherwood, Thomas E Prisinzano, Carol A Paronis, Jack Bergman, Stephen J Kohut

Open access · greenAbstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Reinforcing and Stimulant-Like Effects of Methamphetamine Isomers in Rhesus Macaques.The Journal of pharmacology and experimental therapeutics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Fernando B de MouraBehavioral Biology Program, McLean Hospital, 115 Mill St., Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
Alexander SherwoodUsona Institute, 2780 Woods Hollow Rd., Madison, WI 53711, USA.
Thomas E PrisinzanoCollege of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA.
Carol A ParonisBehavioral Biology Program, McLean Hospital, 115 Mill St., Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
Jack BergmanBehavioral Biology Program, McLean Hospital, 115 Mill St., Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
Stephen J KohutBehavioral Biology Program, McLean Hospital, 115 Mill St., Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA. Electronic address: skohut@mclean.harvard.edu.
Harvard University · USLemuel Shattuck Hospital · USUniversity of Kentucky · USUsona Institute · US

Funding

BUPRENORPHINE: A BEHAVIORAL ANALYSISR01DA002519 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI BERGMAN, JACK · 1985 to 2018
$6.4M
Synthetic Psychoactive "Bath Salt" Effects on Brain Activity and BehaviorR01DA048150 · NIDA · MCLEAN HOSPITAL · PI KOHUT, STEPHEN JOHN · 2019 to 2023
$3.7M
Translational models of brain activation patterns during nicotine self-administration and reinstatementK01DA039306 · NIDA · MCLEAN HOSPITAL · PI KOHUT, STEPHEN JOHN · 2015 to 2019
$867k
NIDA NIH HHS K01 DA039306NIDA NIH HHS R01 DA002519NIDA NIH HHS R01 DA048150
6 · The paper itself

Abstract

The abuse of synthetic cathinones ("bath salts") with psychomotor stimulant and/or entactogenic properties emerged as a public health concern when they were introduced as "legal" alternatives to drugs of abuse such as cocaine or MDMA. In this study, experiments were conducted in nonhuman primates to examine how differences in transporter selectivity might impact the reinforcing effects of synthetic cathinones. Rhesus monkeys (N = 5) were trained to respond for intravenous injections under a fixed-ratio (FR) 30, timeout 60-s schedule of reinforcement. The reinforcing effects of selected cathinones (e.g., MDPV, αPVP, MCAT, and methylone) with a range of pharmacological effects at dopamine and serotonin transporters were compared to cocaine and MDMA using dose-response analysis under a simple FR schedule and behavioral economic procedures that generated demand curves for two doses of each drug. Results show that one or more doses of all drugs were readily self-administered in each subject and, excepting MDMA (21 injections/session), peak levels of self-administration were similar across drugs (between 30 and 40 injections/session). Demand elasticity for the peak and the peak + 1/2-log dose of each drug did not significantly differ, and when data for the two doses were averaged for each drug, the following rank-order of reinforcing strength emerged: cocaine > MCAT = MDPV = methylone > αPVP = MDMA. These results indicate that the reinforcing strength of synthetic cathinones are not related to their selectivity in binding dopamine or serotonin transporter sites.

Indexed as

Reinforcement, PsychologyAlkaloidsAnimalsBehavior, AnimalBenzodioxolesCentral Nervous System StimulantsCocaineDopamine Plasma Membrane Transport ProteinsDose-Response Relationship, DrugFemaleMacaca mulattaMaleMethamphetamineN-Methyl-3,4-methylenedioxyamphetaminePentanonesProtein Binding1-phenyl-2-(1-pyrrolidinyl)-1-pentanoneAlkaloidsBenzodioxolescathinoneCentral Nervous System StimulantsCocaineDopamine Plasma Membrane Transport ProteinsMethamphetaminemethyloneN-Methyl-3,4-methylenedioxyamphetaminePentanonesPyrrolidinesSerotonin Plasma Membrane Transport ProteinsSynthetic CathinoneSynthetic DrugsBehavioral economicsCathinoneRhesus monkeysSelf-administration

Identifiers

PMID33444603
PMCPMC7938610
OpenAlexW3120185061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.